Alaunos Therapeutics, Inc. (TCRT)
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $5.0K
- Net income
- -$4.2M
- Total assets
- $3.0M
- Market cap
- $4.7M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.7M
- Shares outstanding
- 2.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 24, 2005
Alaunos Therapeutics, Inc. (TCRT) Stock Price
- Reported a net loss of $4.2M in FY2025.
- Trading 48% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Alaunos Therapeutics, Inc..
Write a review
News about Alaunos Therapeutics, Inc.
News & sentiment via Polygon.io
Alaunos Therapeutics, Inc.: frequently asked questions
Is Alaunos Therapeutics, Inc. an American company?
Alaunos Therapeutics, Inc. is a US-based company headquartered in Fort Lauderdale, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Alaunos Therapeutics, Inc. headquartered?
Alaunos Therapeutics, Inc. is headquartered in Fort Lauderdale, Florida, United States.
Is Alaunos Therapeutics, Inc. publicly traded?
Yes — Alaunos Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol TCRT on the NASDAQ.
What does Alaunos Therapeutics, Inc. do?
Alaunos Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.